cvs - anti-clotting drugs Flashcards

1
Q

name 4 antiplatelet drugs

A
  1. NSAIDs
  2. platelet GPIIB/IIA receptor blockers
  3. ADP receptor blockers
  4. PDE inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

moa of aspirin

A

inhibit COX-1 → reduce thromboxane A2 and inhibit platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

clinical uses of aspirin

A
  • prophylaxis for transient cerebral ischemia
  • reduce incidence of recurrent MI
  • decrease mortality post-MI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

adverse effects of aspirin

A
  • bleeding
  • gastric upset and ulcers (due to reduced PGE2)
  • reye’s syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

name 3 platelet GP IIB/IIA receptor blockers

A
  1. abciximab
  2. eptifibatide
  3. tirofiban
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

moa of platelet GP IIB/IIA receptor blockers

A

prevent fibrinogen binding and inhibit platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

clinical uses of platelet GP IIB/IIA receptor blockers

A
  • prevent stenosis after coronary angioplasty
  • acute coronary syndromes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

adverse effects of platelet GP IIB/IIA receptor blockers

A
  • thrombocytopenia
  • bleeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

name 2 ADP receptor blockers

A
  1. clopidogrel
  2. ticlopidine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

moa of ADP receptor blockers

A

irreversibly block ADP receptors on platelets, inhibiting activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

name 1 PDE inhibitor

A

dipyridamole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

moa of PDE inhibitor

A

inhibit PDE → prevent breakdown of cAMP to 5’-AMP → increased cAMP → inhibit platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

name 4 anticoagulants

A
  1. heparin derivatives
  2. coumarin derivatives
  3. lepirudin/hirudin
  4. antithrombin III
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

moa of heparin

A
  1. bind to AT III and IIa → allows AT III to get close to IIa to deactivate it
  2. once heparin binds to AT III, it can deactivate Xa wo binding to it
  3. LMWH increases action of AT III on factor Xa (but not on thrombin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

clinical use of heparin

A
  • dvt
  • pulm embolism
  • acute MI
  • anticoagulant for pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how should heparin be administered

17
Q

why can’t heparin be given IM

A

haematomas

18
Q

adverse effects of heparin

A
  • haemorrhage
  • thrombocytopenia
  • osteoporosis w LT use
19
Q

how to treat haemorrhage due to heparin use

A

stop heparin + start protamine sulfate (binds to excess heparin)

20
Q

moa of warfarin

A

vit k reductase inhibitor → inhibit vit K-dep clotting factors (II, VII, IX, X)

21
Q

clinical uses of warfarin

A
  • dvt
  • pulm embolism
  • acute MI
22
Q

adverse effects of warfarin

A
  • bleeding
  • DDI (CYP450)
23
Q

contraindications for warfarin

A

pregnancy (causes haemorrhagic disorders in foetus, foetal proteins w gamma-carboxyglutamate residues affected)

24
Q

moa of lepirudin

A

directly inhibits thrombin

25
Q

moa of antithrombin III

A

enhance inactivation of thrombin and other coagulation enzymes

26
Q

name 4 thrombolytics

A
  1. t-PA
  2. urokinase
  3. streptokinase
  4. anistreplase
27
Q

moa of thrombolytics

A

directly converts plasminogen to plasmin → clot breakdown

28
Q

clinical uses of thrombolytics

A
  • emergency treatment of coronary artery thrombosis
  • peripheral arterial thrombosis and emboli
  • ischaemic stroke
29
Q

adverse effect of thrombolytics

30
Q

contraindications for thrombolytics

A
  • recent surgery
  • bleeding disorders
  • severe uncontrolled hypertension
  • pregnancy
31
Q

moa of t-PA

A

binds to fibrin in a thrombus and converts plasminogen to plasmin → clot breakdown

32
Q

clinical use of t-PA

A

dissolve blood clots in MI/stroke

33
Q

clinical use of urokinase

A
  • severe dvt
  • pulm embolism